1. Sallam, H, McNearney, T, Chen, J. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (Scleroderma). Aliment Pharmacol Ther 2006; 23: 691–712.
Google Scholar | Crossref | Medline2. Shreiner, AB, Murray, C, Denton, C, et al. Gastrointestinal manifestations of systemic sclerosis. J Scleroderma Relat Disord 2016; 1: 247–256.
Google Scholar | SAGE Journals3. Bodukam, V, Hays, R, Maranian, P, et al. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology 2011; 50(2): 330–334.
Google Scholar | Crossref | Medline4. Franck-Larsson, K, Graf, W, Ronnblom, A. Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study. Eur J Gastroenterol Hepatol 2009; 21(2): 176–182.
Google Scholar | Crossref | Medline5. Chevreul, K, Brigham, KB, Gandré, C, et al. The economic burden and health-related quality of life associated with systemic sclerosis in France. Scand J Rheumatol 2015; 44(3): 238–246.
Google Scholar | Crossref | Medline6. Severijnen, AJ, Kool, J, Swaak, AJ, et al. Intestinal flora of patients with rheumatoid arthritis: induction of chronic arthritis in rats by cell wall fragments from isolated Eubacterium aerofaciens strains. Br J Rheumatol 1990; 29(6): 433–439.
Google Scholar | Crossref | Medline7. Olhagen, B, Månsson, I. Intestinal Clostridium perfergins in rheumatoid arthritis and other collagen diseases. Acta Med Scand 2009; 184: 395–402.
Google Scholar | Crossref8. Scher, JU, Sczesnak, A, Longman, RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013; 2: e01202.
Google Scholar | Crossref | Medline9. He, Z, Shao, T, Li, H, et al. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog 2016; 8: 64–67.
Google Scholar | Crossref | Medline10. De Paiva, CS, Jones, DB, Stern, ME, et al. Altered mucosal microbiome diversity and disease severity in Sjögren syndrome. Sci Rep 2016; 6: 1–11.
Google Scholar | Crossref | Medline11. Khanna, D, Hays, RD, Maranian, P, et al. Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument. Arthritis Rheum 2009; 61: 1257–1263.
Google Scholar | Crossref | Medline12. Allegretti, JR, Kassam, Z, Chan, WW. Small intestinal bacterial overgrowth: should screening be included in the pre-fecal microbiota transplantation evaluation. Dig Dis Sci 2018; 63(1): 193–197.
Google Scholar | Crossref | Medline13. Volkmann, ER, Hoffmann-Vold, AM, Chang, YL, et al. Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts. BMJ Open Gastroenterol 2017; 4(1): e000134.
Google Scholar | Crossref | Medline14. Marie, I, Ducrotte, P, Denis, P, et al. Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology 2009; 48: 1314–1319.
Google Scholar | Crossref | Medline15. Yang, M, Zhang, L, Hong, G, et al. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome. J Gastroenterol Hepatol 2020; 35(5): 795–805.
Google Scholar | Crossref | Medline16. Gaulke, CA, Sharpton, TJ. The influence of ethnicity and geography on human gut microbiome composition. Nat Med 2018; 24(10): 1495–1496.
Google Scholar | Crossref | Medline17. Sartor, RB . Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134(2): 577–594.
Google Scholar | Crossref | Medline18. Braun-Moscovici, Y, Braun, M, Khanna, D, et al. What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis? Clin Exp Rheumatol 2015; 33: S117–S122.
Google Scholar | Medline19. Whelan, FJ, Surette, MG. A comprehensive evaluation of the sl1p pipeline for 16S rRNA gene sequencing analysis. Microbiome 2017; 5: 100.
Google Scholar | Crossref | Medline20. Bartram, AK, Lynch, MDJ, Stearns, JC, et al. Generation of multimillion-sequence 16S rRNA gene libraries from complex microbial communities by assembling paired-end Illumina reads. Appl Environ Microbiol 2011; 77(11): 3846–3852.
Google Scholar | Crossref | Medline21. Callahan, BJ, McMurdie, PJ, Rosen, MJ, et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 2016; 13(7): 581–583.
Google Scholar | Crossref | Medline22. Bolyen, E, Rideout, JR, Dillon, MR, et al. QIIME 2: reproducible, interactive, scalable, and extensible microbiome data science. Nat Biotechnol 2018; 37: 852–857.
Google Scholar | Crossref23. Wang, Q, Garrity, GM, Tiedje, JM, et al. Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007; 73: 5261–5267.
Google Scholar | Crossref | Medline24. DeSantis, TZ, Hugenholtz, P, Larsen, N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006; 72(7): 5069–5072.
Google Scholar | Crossref | Medline25. Morgan, XC, Kabakchiev, B, Waldron, L, et al. Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol 2015; 16: 67.
Google Scholar | Crossref | Medline26. Segata, N, Izard, J, Waldron, L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12: R60.
Google Scholar | Crossref | Medline27. Langille, MGI, Zaneveld, J, Caporaso, JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013; 31(9): 814–821.
Google Scholar | Crossref | Medline28. Andréasson, K, Alrawi, Z, Persson, A, et al. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease. Arthritis Res Ther 2016; 18: 278.
Google Scholar | Crossref | Medline29. Polkowska- Pruszyńska, B, Gerkowicz, A, Szczepanik-Kulak, P, et al. Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature. Arch Dermatol Res 2019; 311(1): 1–8.
Google Scholar | Crossref | Medline30. Volkmann, ER, Chang, YL, Barroso, N, et al. Association of systemic sclerosis with a unique colonic microbial consortium. Arthritis Rheumatol 2016; 68(6): 1483–1492.
Google Scholar | Crossref | Medline31. Bellocchi, C, Fernández-Ochoa, Á, Montanelli, G, et al. Microbial and metabolic multi-omic correlations in systemic sclerosis patients. Ann N Y Acad Sci 2018; 1421(1): 97–109.
Google Scholar | Crossref | Medline32. Fava, F, Danese, S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 2011; 17: 557–566.
Google Scholar | Crossref | Medline33. Mukhopadhya, I, Hansen, R, El-Omar, EM, et al. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 2012; 9: 219–230.
Google Scholar | Crossref | Medline34. Hevia, A, Milani, C, López, P, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. Mbio 2014; 5: e01548.
Google Scholar | Crossref | Medline35. Posserud, I, Stotzer, ES, Björnsson, H, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802–808.
Google Scholar | Crossref | Medline36. Randazzo, CL, Pino, A, Ricciardi, L, et al. Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms. J Appl Microbiol 2015; 118(1): 202–211.
Google Scholar | Crossref | Medline37. Tsai, YT, Cheng, PC, Pan, TM. The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 2012; 96(4): 853–862.
Google Scholar | Crossref | Medline38. Volkmann, E, Hoffmann-Vold, A-M, Chang, Y-L, et al. Longitudinal analysis of the gastrointestinal microbiota in systemic sclerosis. Ann Rheumat Dis 2017; 76: 87.
Google Scholar39. Wexler, HM . Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007; 20(4): 593–621.
Google Scholar | Crossref | Medline40. He, Y, Wu, W, Zheng, HM, et al. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat Med 2018; 24: 1532–1535.
Google Scholar | Crossref | Medline41. Sternes, PR, Brown, MA. The gut microbiome and ankylosing spondylitis. In: Khan, M, Mease, P (eds) Axial spondyloarthritis. New York: Elsevier, pp. 87–95.
Google Scholar42. Kaakoush, NO . Insights into the role of Erysipelotrichaceae in the human host. Front Cell Infect Microbiol 2015; 5: 84.
Google Scholar | Crossref | Medline43. Steen, VD, Powell, DL, Medsger, TA Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31(2): 196–203.
Google Scholar | Crossref | Medline44. Patrone, V, Puglisi, E, Cardinali, M, et al. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement. Sci Rep 2017; 7: 14874.
Google Scholar | Crossref | Medline